Denise Bradley

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

Sandra M. Swain, Michael S. Ewer, Giuseppe Viale et al. · Annals of Oncology · 2017 · 247 citations · Full text

Medicine, Oncology, Pharmacology +17

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Rebecca Dent, Mafalda Oliveira, Steven J. Isakoff et al. · Breast Cancer Research and Treatment · 2021 · 74 citations

Medicine, Oncology, Pharmacology +14

Abstract GS3-04: Double-blind placebo (PBO)-controlled randomized phase III trial evaluating first-line ipatasertib (IPAT) combined with paclitaxel (PAC) for <i>PIK3CA/AKT1/PTEN</i>-altered locally advanced unresectable or metastatic triple-negative breast cancer (aTNBC): primary results from IPATunity130 Cohort A

Rebecca Dent, Sung‐Bae Kim, Mafalda Oliveira et al. · Cancer Research · 2021 · 29 citations

Medicine, Oncology, Pharmacotherapy +17

Ipatasertib plus Paclitaxel for Patients with <i>PIK3CA</i> / <i>AKT1</i> / <i>PTEN</i> -Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial

Rebecca Dent, Sung‐Bae Kim, Mafalda Oliveira et al. · Clinical Cancer Research · 2024 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16

Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film‐coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease

Gustavo Varela‐Fascinetto, Corinne Benchimol, Rafael Reyes‐Acevedo et al. · Pediatric Transplantation · 2016 · 22 citations

Medicine, Nephrology, Pediatrics +15